Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 8.3B | 8.1B | 7.4B | 6.3B |
Cost of revenue | 3.9B | 3.8B | 3.5B | 3.1B |
Gross profit | 4.4B | 4.2B | 3.9B | 3.3B |
Operating expense | ||||
Research & development | 774.8M | 736.5M | 665.6M | 553.7M |
Selling general and admin | 781.6M | 721.0M | 617.0M | 672.9M |
Other operating expenses | — | — | — | — |
Operating income | 2.9B | 2.8B | 2.6B | 2.0B |
Non operating interest income | ||||
Income | 153.0M | 139.9M | 132.3M | 132.0M |
Expense | 27.1M | 19.3M | 18.4M | 21.5M |
Other income expense | — | — | — | — |
Pretax income | 3.6B | 2.6B | 3.0B | 2.7B |
Tax provision | 687.0M | 533.2M | 699.1M | 568.5M |
Net income | 2.9B | 2.1B | 2.3B | 2.1B |
Basic EPS | — | 18.3 | 20 | 18.6 |
Diluted EPS | — | 18.3 | 19.9 | 18.4 |
Basic average shares | — | 112.5M | 111.8M | 111.5M |
Diluted average shares | — | 112.7M | 112.5M | 112.7M |
EBITDA | 4.2B | 3.2B | 3.5B | 3.3B |
Net income from continuing op. | 3.6B | 2.6B | 3.0B | 2.7B |
Minority interests | -15.4M | -25.9M | -27.8M | -35.0M |
Preferred stock dividends | 0 | 0 | 0 | 0 |